The U.S. Food and Drug Administration (FDA) has issued a Warning Letter to Brian Manookian, owner of Melanocorp, Inc. in Hendersonville, Tenn. for the illegal sale and marketing of the product Melanotan II, which is not FDA-approved, on Melanocorp’s Web site.
Northwestern University is using an economics theory to rehab people with lousy health habits. Researchers want participants to just change two unhealthy behaviors to see if the others will tag along. Sort of a buy two, get two free sale based on the Behavioral Economics Theory used by Nobel Prize winner Daniel Kahneman. Couch potatoes also get an arsenal of high-tech tools to help them make the changes.
An E. coli outbreak that has sickened six people in Washington, US has led to a federal consumer alert for ground beef products made by Interstate Meats, based in Oregon, US.
The amount of the discount may be less important than the numerical value of the farthest right digit, explains a new study from the Journal of Consumer Research.
Further to the Health Canada warning issued July_26, 2007, further testing on Neem Active Toothpaste with Calcium, manufactured by Calcutta Chemical Co. Ltd in India, has revealed that in addition to unacceptable levels of diethylene glycol (DEG), the product also contains high levels of harmful bacteria.
A University of Adelaide researcher has discovered scientific evidence that obesity is a key factor in infertility – because of how it affects women’s eggs.
Mars Petcare US, Inc. announces a voluntary recall of select five pound bags of Krasdale Gravy dry dog food sold in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania.
Mars Petcare US, Inc. announces a voluntary recall of select 50 lb bags of Red Flannel Large Breed Adult Formula dry dog food sold in two stores in Pennsylvania. Only three bags of product were actually sold, with only one bag still unaccounted for.
Health Canada is advising consumers not to use Excite for women and Ultimates for men due to concerns about possible side-effects.
Health Canada is currently requesting and reviewing new safety information regarding serious liver adverse events in patients using Prexige (lumiracoxib), a Cox-2 inhibitor non-steroidal anti-inflammatory drug (NSAID). Prexige is used in the treatment of osteoarthritis (OA) in adults.